Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
---|
09/16/2009 | EP2099792A1 Heterotricyclic metalloprotease inhibitors |
09/16/2009 | EP2099765A2 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives as antitumor agents |
09/16/2009 | EP2099751A1 Biphenyl-substituted spirocyclic ketoenols |
09/16/2009 | EP2099747A1 Radiolabelling via fluorination of aziridines |
09/16/2009 | EP2099303A1 Therapeutic tetrahydroisoquinoline-based compositions for cancer therapy |
09/16/2009 | EP1283834B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
09/16/2009 | CN101531664A Method for synthesizing a series of camptothecin substituted cinnamate |
09/16/2009 | CN100540538C Large conductance calcium-activated k channel opener |
09/15/2009 | US7589099 Condensation of 7-t-butoxyiminomethylcamptothecin in position 20 with a cyclopeptide containing the RGD sequence; selective cytotoxic activity on human tumor cell lines; antitumor; |
09/15/2009 | US7589096 3-(3-biphenylyl)-5-[3-oxospiro[6-azaisobenzofuran-1(3H),4'-piperidin]-1'-yl]-1H-pyrazole; neuropeptide Y receptor antagonists; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization |
09/15/2009 | US7589077 such as 5-iodo-O6-5'-cyclo-5,6-dihydro-3'-azido-3'-deoxythymidine for prophylaxis or diagnosis of viral diseases caused by hepatitis virus, herpes viruses such as Epstein-Barr virus |
09/15/2009 | US7589068 Inhibitors of Akt activity |
09/15/2009 | CA2230824C Process for the preparation of galanthamine and its derivatives |
09/11/2009 | WO2009111337A1 Compounds and compositions as tlr activity modulators |
09/11/2009 | WO2009110520A1 Heterocyclic compound |
09/11/2009 | WO2009110007A1 Spiro derivatives of parthenin as novel anticancer agents |
09/11/2009 | WO2009109608A1 Novel compounds |
09/11/2009 | WO2009037570A3 Pyridine derivatives and methods of use thereof |
09/11/2009 | CA2728855A1 Spiro derivatives of parthenin as novel anticancer agents |
09/11/2009 | CA2717013A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
09/11/2009 | CA2716706A1 Compounds and compositions as tlr activity modulators |
09/10/2009 | US20090227617 Esters Of Glucuronide Prodrugs Of Anthracyclines And Method Of Preparation And Use In Tumor-Selective Chemotherapy |
09/09/2009 | EP2098512A1 Compounds and methods for treating dyslipidemia |
09/09/2009 | EP2097420A1 Spiroketone acetyl-coa carboxylase inhibitors |
09/09/2009 | EP2097419A1 Benzofuropyrimidinones as protein kinase inhibitors |
09/09/2009 | EP2097402A1 Macrocyclic inhibitors of hepatitis c virus |
09/09/2009 | EP2097400A2 Fused substituted aminopyrrolidine derivative |
09/09/2009 | EP2097376A2 Spiro-piperidine derivatives |
09/09/2009 | EP2096917A2 Cyclopamine analogs |
09/09/2009 | EP1670768B1 Compounds and methods for treating dyslipidemia |
09/09/2009 | CN101528750A Benzimidazole derivatives as selective acid pump inhibitors |
09/09/2009 | CN100537574C Preventive or therapeutic agent for diabetic maculopathy |
09/09/2009 | CN100537538C Nove intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
09/08/2009 | US7585888 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
09/08/2009 | CA2316388C Tetrahydrobenzindole derivative |
09/08/2009 | CA2287558C Heterocyclic derivatives and their use as antithrombotic agents |
09/03/2009 | WO2009108838A1 Bridged, bicyclic heterocyclic or spiro bicyclic heterocyclic derivatives of pyrazolo[1,5-a]pyrimidines, methods for preparation and uses thereof |
09/03/2009 | WO2009108827A1 Fused tricyclic pyrazolo[1, 5-a]pyrimidines, methods for preparation and uses thereof |
09/03/2009 | WO2009087379A3 Tetrahydrofuro (3, 2 -b) pyrrol- 3 -one derivatives as inhibitors of cysteine proteinases |
09/03/2009 | US20090221826 Process for making topotecan |
09/03/2009 | US20090221699 Fab I Inhibitors |
09/03/2009 | US20090221597 Heteroaryl derivatives as cftr modulators |
09/03/2009 | CA2716798A1 Tetrahydrofuropyridones |
09/03/2009 | CA2716499A1 Bridged, bicyclic heterocyclic or spiro bicyclic heterocyclic derivatives of pyrazolo[1,5-a]pyrimidines, methods for preparation and uses thereof |
09/02/2009 | EP2096490A1 Display element and method of driving the same |
09/02/2009 | EP2096113A1 9-substituted camptothecin derivatives as antitumor compounds |
09/02/2009 | EP2094670A1 Heterocyclyc sulfonamides having edg-i antagonistic activity |
09/02/2009 | EP1572215B1 Benzo[d]azepine derivatives for the treatment of neurological disorders |
09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
09/02/2009 | CN101522686A Methods of making esters of camptothecins |
09/02/2009 | CN101522685A Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents |
09/02/2009 | CN101522684A 6-carboxy-normorphinan derivatives, synthesis and uses thereof |
09/02/2009 | CN101519407A Synthesis method of cyclic acid anhydride capable of having substituent group |
09/02/2009 | CN101519404A 15-cyclothiaketone derivative, preparation method and application thereof |
09/02/2009 | CN101519386A Large conductance calcium-activated K channel opener |
09/02/2009 | CN100534993C Spiropyran compound with isocyanate trimer and its preparation method and application |
09/01/2009 | US7582752 Process for the resolution of nefopam |
09/01/2009 | US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
09/01/2009 | US7582658 Bicyclic compound |
09/01/2009 | US7582647 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
09/01/2009 | US7582641 Gyrase inhibitors and uses thereof |
09/01/2009 | US7582632 Tri(cyclo) substituted amide compounds |
09/01/2009 | CA2452432C Active ingredient combination for the pharmacological therapy of nicotine dependence |
08/27/2009 | WO2009105507A2 Beloxepin, its enantiomers, and analogs thereof for the treatment of pain |
08/27/2009 | WO2009104819A1 Benzodiazepine compound and pharmaceutical composition |
08/27/2009 | WO2009086028A3 Carbazole-containing materials in phosphorescent light emitting diodes |
08/27/2009 | US20090216028 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer |
08/27/2009 | US20090216012 Use of centrifugal partition chromatography for purifying galanthamine |
08/27/2009 | US20090215795 Cyclic amidine derivatives |
08/27/2009 | CA2716349A1 Methods for inhibiting drug degradation |
08/27/2009 | CA2715872A1 Benzodiazepine compound and pharmaceutical composition |
08/27/2009 | CA2715192A1 Beloxepin, its enantiomers, and analogs thereof for the treatment of pain |
08/26/2009 | EP2091935A2 Dispiro tetraoxane compounds and their use in the treatment of malaria and/or cancer |
08/26/2009 | EP1861105B1 Process for the preparation of galanthamine hydrobromide |
08/26/2009 | EP1791539B1 Process to prepare camptothecin derivatives |
08/26/2009 | EP1646615B1 Pyrimidine derivatives as modulators of atp-binding cassette transporters |
08/26/2009 | CN101516890A Diaryl ketimine derivative |
08/26/2009 | CN101516889A Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |
08/26/2009 | CN101516879A Preparation and utility of substituted imidazopyridine compounds with hypnotic effects |
08/25/2009 | US7579419 Superior in hole injecting property, making it unnecessary to add a strongly acidic dopant for enhancing hole injecting property; may be useful in flat panel display devices |
08/25/2009 | US7579411 Process for the controlled increase in the molecular weight of polyethylenes |
08/25/2009 | US7579359 imidazonaphthyridines, imidazopyridines, imidazoquinolines, and imidazote-trahydroquinolines; immunomodulators for inducing cytokine biosynthesis; for treatment of viral and neoplastic diseases |
08/25/2009 | US7579356 Thia-tetraazaacenaphthylene kinase inhibitors |
08/25/2009 | US7579022 Photochromic compounds |
08/25/2009 | CA2366932C Cyclic protein tyrosine kinase inhibitors |
08/20/2009 | WO2009103032A1 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases |
08/20/2009 | WO2009102633A1 Hepatitis c virus inhibitors |
08/20/2009 | US20090209608 Deuterium-enriched asenapine |
08/20/2009 | US20090209572 36-Des(3-Methoxy-4-Hydroxycyclohexyl) 36-(3-Hydroxycycloheptyl) Derivatives of Rapamycin for the Treatment of Cancer and Other Disorders |
08/20/2009 | US20090209566 Spirocyclic Compounds |
08/20/2009 | CA2715658A1 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases |
08/20/2009 | CA2715559A1 Hepatitis c virus inhibitors |
08/20/2009 | CA2714087A1 Inhibitors of checkpoint kinases |
08/20/2009 | CA2707442A1 Antibiotic tetrahydro-beta-carboline derivatives |
08/19/2009 | EP2089395A2 New isocarbostyril alkaloid derivatives having anti-proliferative and anti-migratory activities |
08/19/2009 | EP2089382A1 Substituted diazepan compounds as orexin receptor antagonists |
08/19/2009 | EP2089381A1 Indoles which act as via receptor antagonists |
08/19/2009 | CN101511841A Tetrahydrofuro [3, 2 -b] pyrrol-3-ones as cathepsin K inhibitors |
08/19/2009 | CN101511840A Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them |
08/19/2009 | CN101511832A Fused heterocyclic inhibitors of D-amino acid oxidase |